Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A New Role for CXCL4 in Respiratory Syncytial Virus Disease.

ABSTRACT:

SUBMITTER: Wiseman DJ

PROVIDER: S-EPMC7462410 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

A New Role for CXCL4 in Respiratory Syncytial Virus Disease.

Wiseman Dexter J DJ Thwaites Ryan S RS Openshaw Peter J M PJM

American journal of respiratory and critical care medicine 20200901 5

PMID: 32645278

Similar Datasets

Fatal enhanced respiratory syncytial virus disease in toddlers

Project description:This study perfromed RNAseq on two FFPE lung samples from deceased participants from the 1867 RSV vaccine trial and compared these data to age and race matched controls from LungMAP.

2021-10-22 | GSE183435 | GEO

Respiratory syncytial virus: A new era.

Project description:Respiratory syncytial virus (RSV) is a major public health problem that has undergone significant changes in recent years. First of all, it has become easier to diagnose with highly reliable and rapidly available confirmatory tests. This has led to a better understanding of its epidemiology and RSV has gone from being a disease of the pediatric age group, severe only in infants and immunosuppressed children, to being a common disease in people of all ages, particularly important in patients of advanced age or with immunosuppressive diseases. Recent therapeutic and prophylactic advances, both with long-lasting monoclonal antibodies and vaccines, are another reason for satisfaction. For these reasons, the COVID and Emerging Pathogens Committee of the Illustrious Official College of Physicians of Madrid (ICOMEM) has considered it pertinent to review this subject in the light of new knowledge and new resources for dealing with this infection. We have formulated a series of questions that we believe will be of interest not only to members of the College but also to any non-expert in this subject, with a particular focus on the situation of RSV infection in Spain.

| S-EPMC10945101 | biostudies-literature

Respiratory Syncytial virus (RSV)

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-05-29 | GSE232687 | GEO

New Insights on Respiratory Syncytial Virus Prevention.

Project description:Respiratory syncytial virus (RSV) is a well-known infant pathogen transmitted mainly by droplets. It is a leading cause of upper respiratory tract infections in children, usually with a mild course of illness. RSV has also been a threat to older people, especially those with underlying medical conditions. For a long time, prevention was limited to passive immunoprophylaxis with palivizumab for high-risk infants. There was a strong need to find other treatment or prevention methods against RSV infections. In addition, after the coronavirus disease 2019 (COVID-19) pandemic, some significant changes in RSV epidemiology have been observed. Researchers noticed the shift in RSV seasonality and age distribution and the increased number of cases in older infants and adults. All of these made the need to find other medical options even stronger. Fortunately, two protein-based vaccines against RSV have successfully passed all phases of clinical trials and have been approved for use by adults and older people. One of them is also approved for infants from birth to 6 months of age (after maternal immunisation during pregnancy) and for pregnant women between 24 and 36 weeks of pregnancy. Also, a new passive immunisation option named nirsevimab (a highly potent monoclonal antibody with a long half-life) is now available for the paediatric group. In this review, we will discuss the previous and current RSV prevention methods in the light of structural discoveries of RSV antigens.

| S-EPMC10747926 | biostudies-literature

Respiratory syncytial virus

Project description:Respiratory syncytial virus whole genome sequencing

| PRJNA1048457 | ENA

Respiratory syncytial virus

Project description:Respiratory Syncytial Virus Raw sequence reads

| PRJNA371804 | ENA

Respiratory syncytial virus

Project description:Respiratory syncytial virus Genome sequencing and assembly

| PRJNA1251136 | ENA

Respiratory syncytial virus

Project description:Respiratory syncytial virus Raw sequence reads